Answer
The three most commonly reported side effects of Evra in clinical trials were headache (approximately 21.0%), nausea (16.6%) and breast tenderness (15.9%); nausea and breast tenderness occurring at treatment initiation usually diminish after the first three cycles.
Sources for this answer
- EVRA 203 micrograms/24 hours + 33.9 micrograms/24 hours transdermal patchGedeon Richter (UK) Ltd · emc · SmPC §4.8 Undesirable effects · Version 3Document updated
Sources checked